- ICC
Unknown
Immunocytochemistry - Anti-TLR9 antibody (AB62577)
ab62577 at 2μg/ml staining TLR9 in Jurkat cells by Immunocytochemistry.
- WB
Unknown
Western blot - Anti-TLR9 antibody (AB62577)
Lane 1:
Western blot - Anti-TLR9 antibody (ab62577) at 0.5 µg/mL
Lane 2:
Western blot - Anti-TLR9 antibody (ab62577) at 1 µg/mL
Lane 3:
Western blot - Anti-TLR9 antibody (ab62577) at 2 µg/mL
All lanes:
Jurkat cell lysate at 15 µg
Predicted band size: 115 kDa
Observed band size: 95 kDa
false
Reactivity 정보
특성 및 보관 정보
제형
Purification 테크닉
보관 버퍼
배송 시 보관 조건
적절한 단기 보관 조건
적절한 장기 보관 조건
추가 정보
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TLR9 recognizes and binds to microbial DNA triggering an immune response. It is part of the Toll-like receptor family which plays an important role in the innate immune system. TLR9 engages in the formation of complexes with other molecules such as MyD88 an adaptor protein to propagate downstream signaling. This leads to the activation of transcription factors that stimulate cytokine production promoting inflammation and defense against infections.
Pathways
TLR9 participates significantly in the NF-kB activation pathway and the type I interferon signaling cascade. During these processes TLR9 interacts with proteins like IRAK4 and TRAF6. In the NF-kB pathway TLR9's role in the early immune response is coordinated with other Toll-like receptors to detect pathogen-related patterns and initiate adaptive immunity. Its influence on type I interferon signaling facilitates antiviral defense mechanisms.
제품 프로토콜
- Visit the General protocols
- Visit the Troubleshooting
타겟 정보
대체 명칭 보기
제품이 사용된 논문 (1)
Recent publications for all applications. Explore the 전체 목록 and refine your search
Proceedings of the National Academy of Sciences of 112:E1659-68 PubMed25775528
2015
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com